Moderna to request FDA's approval for vaccinating children aged under 6

STORY: Moderna to request FDA's approval for vaccinating children aged under 6 DATELINE: March 24, 2022 LENGTH: 00:01:24 LOCATION: Washington D.C. CATEGORY: HEALTH SHOTLIST: 1. various of American biotechnology company Moderna related footage STORYLINE: American biotechnology company Moderna said Wednesday it will request the U.S. Food and Drug Administration (FDA) to grant emergency use authorization for its COVID-19 vaccine for children aged under 6. The company will submit the request to the FDA, as well as the European Medicines Agency and other global regulators "in the coming weeks," said the company in a statement. The submission was based on tests of its COVID-19 vaccine, known as mRNA-1273, in children aged 6 months to under 2 years, and 2 years to under 6 years. The interim analysis showed a robust neutralizing antibody response in both age groups after a 25 microgram two-dose primary series of mRNA-1273 along with a favorable safety profile, according to the company. In the study, vaccine ef

Pfizer, Moderna seek FDA's authorization for second COVID-19 booster shots

STORY: Pfizer, Moderna seek FDA's authorization for second COVID-19 booster shots DATELINE: March 19, 2022 LENGTH: 00:02:36 LOCATION: Washington D.C. CATEGORY: HEALTH SHOTLIST: 1. various of the vaccine production line STORYLINE: American biotechnology company Moderna submitted a request to the U.S. Food and Drug Administration (FDA) on Thursday for emergency use authorization (EUA) on a fourth dose of its COVID-19 vaccine for adults 18 years of age and older, who already received a booster dose of any approved or authorized shot. The request to include adults over 18 years of age was made to provide flexibility for the U.S. Centers for Disease Control and Prevention and healthcare providers to "determine the appropriate use of an additional booster dose," including for those at higher risk of COVID-19 due to age or comorbidities, said the company in a statement. Currently a booster dose of the Moderna COVID-19 vaccine at the 50 microgram dose level is authorized by the FDA for emergency use in the Unite